SCHEMBL25499775

SCHEMBL25499775

CCOC(=O)CCCCON1C(=O)CCC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 1/20 0.45
CYP1A2 P05177 1/20 0.43
TBXAS1 P24557 2/20 0.41
BRD4 O60885 1/20 0.41
LMNA P02545 1/20 0.41
DGKA P23743 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
RAB9A P51151 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
NAMPT P43490 1/20 0.39
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 3/20 0.38
ALDH1A1 P00352 2/20 0.38
ALOX15 P16050 2/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11288016 0.83 NOTUM (0.50) ALOX12TBXAS1BRD4RAB9ACYP4F2
SCHEMBL17256327 0.83 CYP1A2 (0.44) CYP1A2BRD4DGKAL3MBTL1RAB9A
SCHEMBL22193741 0.82 ALOX12 (0.49) ALOX12LMNAKMT2ASMN1; SMN2TDP1
SCHEMBL6358200 0.81 CYP1A2 (0.46) CYP1A2BRD4LMNAL3MBTL1RAB9A
SCHEMBL8744647 0.80 ALOX12 (0.46) ALOX12BRD4LMNADGKAL3MBTL1
SCHEMBL14866439 0.79 ALOX12 (0.46) ALOX12BRD4LMNADGKAKMT2A
SCHEMBL4700272 0.79 BRD4 (0.42) CYP1A2BRD4LMNADGKAL3MBTL1
SCHEMBL8652116 0.78 ALOX12 (0.56) ALOX12TBXAS1LMNAKMT2ASMN1; SMN2
SCHEMBL21352287 0.78 DGKA (0.42) ALOX12LMNADGKAKMT2ASMN1; SMN2
SCHEMBL7466378 0.78 SMN1; SMN2 (0.50) CYP1A2L3MBTL1RAB9ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151411-A1 SELECTIVELY CONTROLLABLE CLEAVABLE LINKERS MICROSOFT TECHNOLOGY LICENSING, LLC 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151411-A1 SELECTIVELY CONTROLLABLE CLEAVABLE LINKERS DNPEP, ADAM8, ADAM10 ALOX12 2824/4885CYP1A2 1921/4885TBXAS1 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.